Clinical Trial Update: SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of Korea

View source ↗

Summary

Clinical trial update for a safety study of Pradaxa (dabigatran) in atrial fibrillation patients conducted due to regulatory requirements in Korea; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2019-03-08